Jbt Marel vs Kadant
JBTM and KAI side by side, both in special industry machinery, except metalworking. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How JBTM and KAI compare
Jbt Marel is the larger company, worth 1.9 times as much as Kadant ($6.5B against $3.5B).
On earnings, Kadant is cheaper: it trades at 29.7× trailing earnings, against 34.1× for Jbt Marel.
Jbt Marel grew revenue faster over the last twelve months (44.9% versus 16.6% for Kadant).
Kadant keeps more of each dollar of sales as profit, with a net margin of 9.8% compared with 4.9% at Jbt Marel.
Both pay dividends: Jbt Marel yields 0.32% and Kadant 0.48%.
Kadant scores higher on the StockData Score (19 against 12 for Jbt Marel), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | JBTM | KAI |
|---|---|---|
| Size and price | ||
| Market cap | $6.5B | $3.5B |
| Share price | $125.54 | $294.21 |
| Change, 1 year | −10.8% | 10.9% |
| Change, 5 years | −27.7% | 25.3% |
| Beta (5Y) | 0.94 | 1.00 |
| Employees | 12K | 3,900 |
| StockData Score | ||
| Total score | 12 | 19 (better) |
| Valuation score | 2 | 3 (better) |
| Growth score | 2 | 3 (better) |
| Performance score | 0 | 4 (better) |
| Health score | 4 | 5 (better) |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 34.1× | 29.7× (better) |
| P/S | 1.7× (better) | 2.9× |
| P/B | 1.5× (better) | 3.3× |
| EV/EBITDA | 28.0× | 15.5× (better) |
| P/FCF | 21.0× | 20.0× (better) |
| FCF yield | 4.8% | 5.0% (better) |
| Fair value | $115.41 | $283.20 |
| Margin of safety | −8.8% | −3.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 44.9% (better) | 16.6% |
| Revenue growth, 5Y average | 17.1% (better) | 10.6% |
| Net income growth (TTM) | – | 14.8% |
| EPS growth (TTM) | – | 14.5% |
| EPS growth, 5Y average | – | 12.6% |
| Profitability | ||
| Gross margin | 35.6% | 44.4% (better) |
| Operating margin | 7.3% | 15.4% (better) |
| Net margin | 4.9% | 9.8% (better) |
| FCF margin | 7.9% | 14.6% (better) |
| Return on equity | 4.3% | 11.7% (better) |
| Return on invested capital | 3.8% | 10.8% (better) |
| Financial health | ||
| Debt / equity | 0.38 (better) | 0.43 |
| Net debt / EBITDA | 5.46 | 1.31 (better) |
| Interest coverage | – | 8.9× |
| Current ratio | 1.24 | 2.49 (better) |
| Altman Z-score | 2.03 | 4.53 (better) |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.32% | 0.48% (better) |
| Payout ratio | 10.9% | 14.1% |
| Years of dividend growth | 0 | 13 (better) |
| Dividend growth, 5Y average | 0.00% | 7.2% (better) |
| Buyback yield | – | −0.07% |
| Shareholder yield | 0.32% | 0.41% (better) |
| Ownership | ||
| Held by institutions | 103% | 111% |
| Held by insiders | 1.4% | 1.2% |
| Insider net buying, 12 months | −$4.3M | −$861K (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 8.0% | 6.8% |
Go deeper
- JBTM stock overview
- JBTM income statement
- JBTM valuation and score
- KAI stock overview
- KAI income statement
- KAI valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.